Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Bouncing or biofeedback: which eases endometriosis pain better?

NCT ID NCT06517654

Symptom relief Sponsor: Medipol University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two pelvic floor muscle strengthening methods—EMG-biofeedback and rebound therapy (gentle bouncing)—in 42 women with endometriosis. The goal was to see which better reduces pain, improves muscle strength, and boosts quality of life. Participants had moderate to severe pain and were not on medical treatment for endometriosis during the study.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

42 people

The number who actually took part.

Started

Sep 2024

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 50 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Being between 20-50 years old, * Being diagnosed with endometriosis, * Completing the voluntary consent form, * Pain level being at least 4 on the Visual Analog Scale (VAS). Exclusion Criteria: Exclusion Criteria for the EMG-Biofeedback Group: * Being included in another study during the study period, * Being receiving medical treatment for endometriosis, * Presence of gynecological bleeding, * Presence of communication and cooperation problems, * Presence of tubo-ovarian abscess, * Active vaginal or urinary tract infection, * Pregnancy and giving birth within the last 12 months, * Presence of impaired somatosensory status, * Not attending 2 consecutive sessions. Exclusion Criteria for the Rebound Therapy Group: In addition to the exclusion criteria determined for the EMG-Biofeedback Group; * Presence of a neurological or orthopedic disease affecting the lower extremity, * History of spine and/or lower extremity orthopedic surgery, * Presence of severe arthritis affecting the spine and/or lower extremity, * Presence of uncontrolled hypertension and cardiovascular disease.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Endometriosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

endometriosis insomnia Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Endometriosis

Contacts and locations

Locations

  • Zeynep Kamil Women and Children's Diseases Training and Research Hospital

    Üsküdar, Istanbul, 34668, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.